U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook

Name: U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell & gene therapy bioanalytical testing services market in the United States is expected to reach a projected revenue of US$ 314.4 million by 2030. A compound annual growth rate of 7.5% is expected of the United States cell & gene therapy bioanalytical testing services market from 2024 to 2030.

HC Outsourcing
- Clinical & Non-Clinical Outsourcing Services
  - Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

U.S. cell & gene therapy bioanalytical testing services indication outlook (Revenue, USD million, 2018-2030)
- Infectious Diseases
- Rare Diseases
- Oncology
- Others
- Neurological disorders
U.S. cell & gene therapy bioanalytical testing services test type outlook (Revenue, USD million, 2018-2030)
- Other test type
- Pharmacodynamics
- Bioavailability & Bioequivalence Studies
- Pharmacokinetics
U.S. cell & gene therapy bioanalytical testing services product outlook (Revenue, USD million, 2018-2030)
- Cell Therapy
- Gene-Modified Cell Therapy
  - CAR-NK cell therapy
  - CAR T-cell therapies
  - Other
  - TCR-T cell therapy
- Gene Therapy
  - Ex-vivo
  - In-vivo
U.S. cell & gene therapy bioanalytical testing services stage of development outlook (Revenue, USD million, 2018-2030)
- Clinical
  - Gene-Modified Cell Therapy
  - Cell Therapy
  - Gene Therapy
- Non-Clinical
  - Gene Therapy
  - Gene-Modified Cell Therapy
  - Cell Therapy

U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook

Data Tree

Sign up - it's easy, and free!